Cargando…

LBODP007 Clinical Characteristics And Treatment Outcomes Of Adrenal Histoplasmosis And Tuberculosis In Thailand: A 15-year Retrospective Study In A Single Tertiary Center

BACKGROUND: Adrenal histoplasmosis and tuberculosis (TB) are the most common adrenal infections. These conditions are widely reported in developing countries. METHODS: We performed a retrospective study of patients with adrenal histoplasmosis and TB at King Chulalongkorn Memorial Hospital, Bangkok,...

Descripción completa

Detalles Bibliográficos
Autores principales: Vorasayun, Thanyaporn, Porntharukchareon, Thachanun, Plongla, Rongpong, Snabboon, Thiti, Sunthornyothin, Sarat, Parksook, Wasita Warachit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624852/
http://dx.doi.org/10.1210/jendso/bvac150.083
_version_ 1784822338336849920
author Vorasayun, Thanyaporn
Porntharukchareon, Thachanun
Plongla, Rongpong
Snabboon, Thiti
Sunthornyothin, Sarat
Parksook, Wasita Warachit
author_facet Vorasayun, Thanyaporn
Porntharukchareon, Thachanun
Plongla, Rongpong
Snabboon, Thiti
Sunthornyothin, Sarat
Parksook, Wasita Warachit
author_sort Vorasayun, Thanyaporn
collection PubMed
description BACKGROUND: Adrenal histoplasmosis and tuberculosis (TB) are the most common adrenal infections. These conditions are widely reported in developing countries. METHODS: We performed a retrospective study of patients with adrenal histoplasmosis and TB at King Chulalongkorn Memorial Hospital, Bangkok, Thailand, from 2005 to 2020, and evaluated clinical characteristics, treatment, and outcomes. The diagnosis was made by proven microbiologic evidence of infection and morphologic adrenal abnormalities by cross-sectional imaging. RESULTS: Of all 27 patients, 20 had adrenal histoplasmosis, 6 had adrenal TB, and 1 had coinfection with both pathogens. The majority of the patients had bilateral adrenal involvement (93%). Most patients were males (81%), and the mean age was 62 years. Ninety-six percent of patients did not have HIV infection. The most frequent comorbidities were hypertension (50%) and diabetes mellitus (23%). Common presentations were weight loss and anorexia (77%), and fever (65%), in which the median time from the presentation to diagnosis was 3.5 months. The prevalence of adrenal insufficiency was 67%. All patients with adrenal insufficiency received steroid replacement, yet 17% had an adrenal crisis during the treatment course. Ninety-six percent of patients received medical treatment (antituberculosis or antifungal agents), while almost half needed additional surgery (44%). During a median follow-up period of 20.5 months, the mortality rates were 28.5%, in which all death was from patients with adrenal histoplasmosis or coinfection with histoplasmosis and TB. CONCLUSION: There were high rates of adrenal insufficiency in patients with adrenal histoplasmosis and TB. High mortality rates were also observed, particularly in adrenal histoplasmosis. Appropriate management of these conditions is required from both infectious and hormonal perspectives. Presentation: No date and time listed
format Online
Article
Text
id pubmed-9624852
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-96248522022-11-14 LBODP007 Clinical Characteristics And Treatment Outcomes Of Adrenal Histoplasmosis And Tuberculosis In Thailand: A 15-year Retrospective Study In A Single Tertiary Center Vorasayun, Thanyaporn Porntharukchareon, Thachanun Plongla, Rongpong Snabboon, Thiti Sunthornyothin, Sarat Parksook, Wasita Warachit J Endocr Soc Adrenal BACKGROUND: Adrenal histoplasmosis and tuberculosis (TB) are the most common adrenal infections. These conditions are widely reported in developing countries. METHODS: We performed a retrospective study of patients with adrenal histoplasmosis and TB at King Chulalongkorn Memorial Hospital, Bangkok, Thailand, from 2005 to 2020, and evaluated clinical characteristics, treatment, and outcomes. The diagnosis was made by proven microbiologic evidence of infection and morphologic adrenal abnormalities by cross-sectional imaging. RESULTS: Of all 27 patients, 20 had adrenal histoplasmosis, 6 had adrenal TB, and 1 had coinfection with both pathogens. The majority of the patients had bilateral adrenal involvement (93%). Most patients were males (81%), and the mean age was 62 years. Ninety-six percent of patients did not have HIV infection. The most frequent comorbidities were hypertension (50%) and diabetes mellitus (23%). Common presentations were weight loss and anorexia (77%), and fever (65%), in which the median time from the presentation to diagnosis was 3.5 months. The prevalence of adrenal insufficiency was 67%. All patients with adrenal insufficiency received steroid replacement, yet 17% had an adrenal crisis during the treatment course. Ninety-six percent of patients received medical treatment (antituberculosis or antifungal agents), while almost half needed additional surgery (44%). During a median follow-up period of 20.5 months, the mortality rates were 28.5%, in which all death was from patients with adrenal histoplasmosis or coinfection with histoplasmosis and TB. CONCLUSION: There were high rates of adrenal insufficiency in patients with adrenal histoplasmosis and TB. High mortality rates were also observed, particularly in adrenal histoplasmosis. Appropriate management of these conditions is required from both infectious and hormonal perspectives. Presentation: No date and time listed Oxford University Press 2022-11-01 /pmc/articles/PMC9624852/ http://dx.doi.org/10.1210/jendso/bvac150.083 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Adrenal
Vorasayun, Thanyaporn
Porntharukchareon, Thachanun
Plongla, Rongpong
Snabboon, Thiti
Sunthornyothin, Sarat
Parksook, Wasita Warachit
LBODP007 Clinical Characteristics And Treatment Outcomes Of Adrenal Histoplasmosis And Tuberculosis In Thailand: A 15-year Retrospective Study In A Single Tertiary Center
title LBODP007 Clinical Characteristics And Treatment Outcomes Of Adrenal Histoplasmosis And Tuberculosis In Thailand: A 15-year Retrospective Study In A Single Tertiary Center
title_full LBODP007 Clinical Characteristics And Treatment Outcomes Of Adrenal Histoplasmosis And Tuberculosis In Thailand: A 15-year Retrospective Study In A Single Tertiary Center
title_fullStr LBODP007 Clinical Characteristics And Treatment Outcomes Of Adrenal Histoplasmosis And Tuberculosis In Thailand: A 15-year Retrospective Study In A Single Tertiary Center
title_full_unstemmed LBODP007 Clinical Characteristics And Treatment Outcomes Of Adrenal Histoplasmosis And Tuberculosis In Thailand: A 15-year Retrospective Study In A Single Tertiary Center
title_short LBODP007 Clinical Characteristics And Treatment Outcomes Of Adrenal Histoplasmosis And Tuberculosis In Thailand: A 15-year Retrospective Study In A Single Tertiary Center
title_sort lbodp007 clinical characteristics and treatment outcomes of adrenal histoplasmosis and tuberculosis in thailand: a 15-year retrospective study in a single tertiary center
topic Adrenal
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624852/
http://dx.doi.org/10.1210/jendso/bvac150.083
work_keys_str_mv AT vorasayunthanyaporn lbodp007clinicalcharacteristicsandtreatmentoutcomesofadrenalhistoplasmosisandtuberculosisinthailanda15yearretrospectivestudyinasingletertiarycenter
AT porntharukchareonthachanun lbodp007clinicalcharacteristicsandtreatmentoutcomesofadrenalhistoplasmosisandtuberculosisinthailanda15yearretrospectivestudyinasingletertiarycenter
AT plonglarongpong lbodp007clinicalcharacteristicsandtreatmentoutcomesofadrenalhistoplasmosisandtuberculosisinthailanda15yearretrospectivestudyinasingletertiarycenter
AT snabboonthiti lbodp007clinicalcharacteristicsandtreatmentoutcomesofadrenalhistoplasmosisandtuberculosisinthailanda15yearretrospectivestudyinasingletertiarycenter
AT sunthornyothinsarat lbodp007clinicalcharacteristicsandtreatmentoutcomesofadrenalhistoplasmosisandtuberculosisinthailanda15yearretrospectivestudyinasingletertiarycenter
AT parksookwasitawarachit lbodp007clinicalcharacteristicsandtreatmentoutcomesofadrenalhistoplasmosisandtuberculosisinthailanda15yearretrospectivestudyinasingletertiarycenter